Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes

hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes

US Patent 8658778 · Granted Feb 25, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for TUSC2 immunotherapy2025
Methods and compositions for TUSC2 immunotherapy2025
Methods and compositions for TUSC2 immunotherapy2022
Methods and compositions for TUSC2 immunotherapy2022
Methods and compositions for non-viral gene therapy for treatment of hyperprolif2019
Chromosome 3p21.3 genes are tumor suppressors2018
Chromosome 3p21.3 genes are tumor suppressors2018
TUSC2 therapies2017
Oncogenic ras-specific cytotoxic compound and methods of use thereof2014
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes2014
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes2014
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes2012